SCHEMBL30273755

SCHEMBL30273755

Cn1c(=O)n(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)c2ccc(Nc3cccc(CC(=O)O)c3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 1/20 0.40
▸ BCL6 P41182 1/20 0.37
▸ PDE5A O76074 1/20 0.36
▸ CYSLTR1 Q9Y271 2/20 0.35
▸ CYSLTR2 Q9NS75 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ ENPP2 Q13822 1/20 0.34
▸ SRD5A2 P31213 1/20 0.34
▸ PKM P14618 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ CCKBR P32239 1/20 0.34
▸ PIK3CA P42336 1/20 0.33
▸ PRKDC P78527 1/20 0.33
▸ TRIM24 O15164 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ BAK1 Q16611 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30273779 0.94 HDAC6 (0.39) HDAC6BCL6CYSLTR1CYSLTR2GRM5
SCHEMBL30026783 0.90 PRKDC (0.40) HDAC6BCL6GRM5SRD5A2PKM
SCHEMBL23540670 0.90 PRKDC (0.40) HDAC6BCL6GRM5SRD5A2PKM
SCHEMBL31396987 0.90 CTSV (0.35) HDAC6BCL6GRM5SRD5A2PIK3CA
SCHEMBL31304868 0.88 PKM (0.38) HDAC6BCL6GRM5SRD5A2PKM
SCHEMBL31397430 0.87 FFAR1 (0.41) GRM5ENPP2SRD5A2PKMFFAR1
SCHEMBL31554664 0.86 LMNA (0.43) BCL6CYSLTR1CYSLTR2GRM5SRD5A2
SCHEMBL23540506 0.85 RIPK1 (0.36) HDAC6BCL6GRM5SRD5A2PKM
SCHEMBL31397273 0.85 BCL6 (0.35) HDAC6BCL6GRM5SRD5A2PKM
SCHEMBL24818101 0.84 GRM5 (0.37) GRM5SRD5A2PKMFFAR1TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC 2025-10-02 — — US disclosed
US-20240424111-A1 Degrader Compounds and Uses Thereof CALICO LIFE SCIENCES LLC (US) 2024-12-26 — — US disclosed
WO-2023019166-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC (US) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS PTPN1, PTPN2, PTPN18 HDAC6 1558/4885BCL6 401/4885PDE5A 2402/4885
US-20240424111-A1 Degrader Compounds and Uses Thereof PTPN1, PTPN2, PTPN5 HDAC6 2793/4885BCL6 936/4885PDE5A 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback